Home » Topics » BioWorld Science

BioWorld Science
RSS

Ovid reports topline phase II data with OV-101 in fragile X syndrome

May 8, 2020

Positive topline data presented from phase IIa study of HTD-1801 in NASH and T2DM

May 8, 2020

New adenosine A2B receptor antagonists patented by Leadxpro

May 8, 2020

Chinese researchers identify new TLR7 agonists

May 8, 2020

FDA approves the initiation of phase II COVID-19 studies of PUL-042

May 8, 2020

Abbisko Therapeutics identifies RORC agonists

May 8, 2020

Sage Therapeutics discloses GABA-A receptor modulators

May 8, 2020

Roche patents new antivirals for HBV infection

May 8, 2020

DEP irinotecan enters phase II testing after positive phase I data

May 8, 2020

Remdesivir receives Japanese approval for severe COVID-19

May 8, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...